Research Notes: ranitidine breast cancer lawsuit: what to know about legal options for Zantac (ranitidine)

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Recommended deep-dive

ranitidine breast cancer lawsuit: what to know about legal options for Zantac (ranitidine) — Research Summary

A focused review of background, context, and source material on this subject.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.